Kahira Pharmaceuticals & Chemical Industries (CPCI) Stock Overview
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CPCI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Kahira Pharmaceuticals & Chemical Industries Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م357.04 |
| 52 Week High | ج.م383.00 |
| 52 Week Low | ج.م160.00 |
| Beta | 0.27 |
| 1 Month Change | 23.13% |
| 3 Month Change | 39.98% |
| 1 Year Change | 106.06% |
| 3 Year Change | 839.33% |
| 5 Year Change | 864.97% |
| Change since IPO | 871.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| CPCI | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 3.1% | 8.1% | 2.9% |
| 1Y | 106.1% | 124.1% | 57.4% |
Return vs Industry: CPCI underperformed the EG Pharmaceuticals industry which returned 120.7% over the past year.
Return vs Market: CPCI exceeded the EG Market which returned 57.7% over the past year.
Price Volatility
| CPCI volatility | |
|---|---|
| CPCI Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in EG Market | 8.3% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: CPCI's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: CPCI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of EG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 1,708 | Bassem Abdallah | kahirapharma.net |
Kahira Pharmaceuticals & Chemical Industries Company manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally. It offers various pharmaceutical dosage forms, medical preparations, cosmetics, chemicals, extracts, veterinary medicines, and pesticides. The company is also involved in support services, including combination formulations.
Kahira Pharmaceuticals & Chemical Industries Company Fundamentals Summary
| CPCI fundamental statistics | |
|---|---|
| Market cap | ج.م5.26b |
| Earnings (TTM) | ج.م466.89m |
| Revenue (TTM) | ج.م2.28b |
Is CPCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPCI income statement (TTM) | |
|---|---|
| Revenue | ج.م2.28b |
| Cost of Revenue | ج.م1.47b |
| Gross Profit | ج.م809.77m |
| Other Expenses | ج.م342.88m |
| Earnings | ج.م466.89m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 31.26 |
| Gross Margin | 35.51% |
| Net Profit Margin | 20.47% |
| Debt/Equity Ratio | 14.1% |
How did CPCI perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/12 06:07 |
| End of Day Share Price | 2026/05/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kahira Pharmaceuticals & Chemical Industries Company is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mohamed Antar Hassan | CI Capital Research |
| Mohamed Hamza | Pharos Research |